XHUA continues its uptrend off a bottom made earlier this year. With excellent confirmation from various indicators, this is a chart you will definitely want on your watch list. Please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=393 Let us hear your thoughts below:
INFRAX SYSTEMS Inc., in the process of acquiring Trimax Wireless, yesterday updated a previous announcement regarding Trimax’s first phase of the network deployment which is being built for a customer in Abuja, Nigeria. The network is based on the TMAX™ wireless broadband platform, and has been equipped with solar power for remote locations. The network will deliver high-speed Internet service and low-cost telephone service to the entire Abuja region. Today the companies announced that Trimax is now moving forward with the second phase of the deployment, in which it will add the next tier of base stations spanning three of…
This morning before the opening bell, Micro Identification Technologies, Inc. announced it was featured in an editorial published by U.S. Equity News that covers the history of bacteria, its life threatening effects, and publicly traded companies leading the fight against harmful bacteria. The entire piece can be found at the following link: http://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=30329318&webmasterId=89753. In the editorial U.S. Equity News stated, “Although giant pharmaceutical companies remain the biggest players in the war against bacteria, one of the most unique breakthroughs in the science belongs to a little company out of San Clemente, California called Micro Identification Technology (“MIT”). The company has…
Micro Identification Technologies, Inc. today announced that it has secured an equity financing commitment of up to $5,000,000 from a private equity firm, Dutchess Capital through its Dutchess Opportunity Fund, LP. During the 3-year term of this equity commitment, Micro Identification Technologies will be able to sell shares of its common stock to Dutchess Capital up to the total committed amount. Although MIT will be able to determine at its sole discretion the amount and timing of any sales of these shares, the sales are subject to certain conditions which will be provided in an 8-K filing with the SEC.…
Defentect Group, Inc. is a developer and provider of rapid response software applications for the threat detection industry. The Company develops software applications that are critical to coordinating rapid responses to chemical, biological, radiological, nuclear, and explosive (CBRNE) threats. Founded in 2000, Defentect Group, Inc. has their headquarters in Norwalk, Connecticut. Formerly known as Splinternet Holdings, Inc., the Company changed their name to Defentect Group, Inc. in March 2010. Their flagship solution, DM3™, is an unattended gamma radiation detection-network. It integrates data from a wide-area pervasive grid of sensors to an incident command center. DM3™ is networked using IP and…
Newport Digital Technologies, Inc. is constantly focused on securing innovative and highly marketable new intellectual property via its exclusive partnerships with two of the world’s leading technology incubators based in Taiwan and consisting of some 8k of the planet’s top engineers and scientists: • The Institute for Information Industry (III) is a global leader in RFID and WiMAX with a proven track record for outstanding design and implementation of large scale information systems, like Taiwan’s massive e-Government project, whose success is rivaled only by the III’s success in developing strategic relationships within Taiwan’s IT industry. • The Industrial Technology Research…
Envision Solar International, Inc., a global leader in solar solutions which offers planning, architectural services, design services and professional implementation of some of the very finest in long-term customized solar installations for companies seeking a comprehensive sustainability profile, announced solar integrated building solutions today. Geared towards top US companies looking to improve their renewable energy capacity, the Company is one of the first worldwide to really tackle the millions of acres of unused and underused space dedicated to parking by inventing solar additions and incorporating solar-to-electric charging stations for EVs into their design. With over 9 MW of installed solar…
Biotechnology company International Stem Cell Corp. today posted the results of a second set of experiments on lab-grown corneal tissue. The results support previous studies that show the tissue as similar to drug absorption and drug metabolism characteristics found in normal corneal tissue, confirming the potential therapeutic value in treating corneal injury and disease, and suggesting the tissue’s potential as a replacement to animal testing. ISCO's human corneal tissue is created in the laboratories of its wholly owned subsidiary, Lifeline Cell Technology. The company said that additional experiments will be conducted to better define optical characteristics shown in the experiments.…
National Automation Services Inc., an automation and control systems integration company gearing up for both geographical and industrial expansion, is continuing its preparations to acquire a number of local and regional automation control service companies around the country. With its recent significant announcement that it has obtained an equity financing commitment of $5 million from Ascendiant Capital Group, LLC, a private equity firm, and its affiliate, Ascendiant Equity Partners, LLC, NASV has taken a major step in furthering that business plan. The financing agreement has a 24-month term, during which NAS may sell shares of its common stock to Ascendiant…
Product development cycles are an aspect of new product development that many investors fail to address as they go about assessing a company. Some years are "work" years while others find revenue growth from work performed years ago. An investor that can find and recognize when that revenue growth is about to happen is one that will profit. Novabay Pharmaceuticals Inc., a clinical stage specialty pharmaceuticals company, works to develop synthetic anti-infective products for in-hospital and out-patient applications. The company's latest product, based on synthetic N-chlorinated molecules, is showing solid progress in later stage development. These results could lead to…
